Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
22 hedge funds and large institutions have $5.02M invested in Calithera Biosciences, Inc in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 7 closing their positions.
13% more capital invested
Capital invested by funds: $4.44M → $5.02M (+$586K)
21% less funds holding
Funds holding: 28 → 22 (-6)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.6K |
| 2 |
JP Morgan Chase
New York
|
+$48.8K |
| 3 |
Renaissance Technologies
New York
|
+$47.4K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.12K |
| 5 |
AIM
Axiom Investment Management
New York
|
+$855 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$123K |
| 2 |
Two Sigma Investments
New York
|
-$49K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$40.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$40.3K |
| 5 |
VF
Virtu Financial
New York
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LC
26
Lindbrook Capital
Calabasas,
California
| – | -$1K | -500 | Closed |
|
27
Citigroup
New York
| – | -$1.57K | -459 | -97% |
|
|
TC
28
Truvestments Capital
Sarasota,
Florida
| – | -$41 | -12 | -19% |
|
|
AIM
29
Axiom Investment Management
New York
| – | +$855 | +250 | New |
|
CALA Hedge Fund Activity: Q3 2022 in Review
22 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2022, worth a combined $5.02M — up 13% from $4.44M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CALA and 2 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $91.6K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $123K sold.
- 22 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2022, down from 28 in Q2 2022.
- Funds reported $5.02M of Calithera Biosciences, Inc stock for Q3 2022, up 13% quarter-over-quarter.
- 2 funds opened new Calithera Biosciences, Inc positions in Q3 2022 and 7 closed out, a net change of -5 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2022 was Vanguard Group, an estimated $91.6K added.
- The largest Calithera Biosciences, Inc seller in Q3 2022 was Alyeska Investment Group, an estimated $123K sold.
Based on aggregated 13F filings for Q3 2022.